Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis

Journal of Translational Medicine(2024)10.1186/s12967-024-05205-8Source: DataRank Database

Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis is a research paper published in Journal of Translational Medicine (2024). On theSindex it has a DataRank of 0.615. It has been cited 19 times, with 16 citing works in its 1-hop citation network.

N/A

0.615DataRank · unranked

Scored on demand from live citation data

Open Access19 citations · 16 citing works in its network

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 7.93)OA: goldTopics (45)Linked Datasets (6)DataCite Reuse (6)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 73%Citation Network 27%

Base Score Contribution

0.449

From this paper's citation signal

Citation Network Contribution

0.165

From 9 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 16 citers.

Multi-dimensional omics integrated machine learning framework identifies macrophage-fibroblast-tumor co-infiltration patterns to predict prognosis in gastric cancer
npj Digital Medicine20259 citations38 referencesContributes 0.061
Redefining the tumor microenvironment with emerging therapeutic strategies
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics202415 citations71 referencesContributes 0.039
Chemotherapy response in primary peritoneal small cell carcinoma
Discover Oncology20251 citations32 referencesContributes 0.022
Rewiring the T cell-suppressive cytokine landscape of the tumor microenvironment: a new frontier for precision anti-cancer therapy
Frontiers in Immunology202419 citations192 referencesContributes 0.016
Immunotherapy biomarkers in brain metastases: insights into tumor microenvironment dynamics
Frontiers in Immunology20256 citations155 referencesContributes 0.013

Authors (12)

Christopher Sherry,Jenna Zimmerman,Hyun Park ORCID,Catherine Lewis,Albert D. Donnenberg ORCID

Live enrichment

PubMed:38689325 PMC:PMC11061933 OpenAlex:https://openalex.org/W4396531838

A Glimmer of Hope

Grant: A Glimmer of Hope

NIH HHS

Grant: R21 OD034476

NHLBI NIH HHS

Grant: T32 HL160526

NCI NIH HHS

Grant: R37 CA232209

NCI NIH HHS

Grant: R01 CA114246

National Institutes of Health

Grant: 1R01CA114246-01A1

Injectable Engineered Tissue for Cancer Reconstruction

National Institutes of Health

Grant: 5R37CA232209-07

Three-dimensional organoid models to study breast cancer progression

National Institutes of Health

Grant: 5T32HL160526-02

Cardiothoracic Surgery Research Training Program

FWCI

7.93

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1186/s12967-024-05205-8.pdf

publisherhttps://link.springer.com/content/pdf/10.1186/s12967-024-05205-8.pdf

publisherhttps://link.springer.com/article/10.1186/s12967-024-05205-8/fulltext.html

journalhttps://doi.org/10.1186/s12967-024-05205-8

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38689325

Fields of Study

Intraperitoneal and Appendiceal MalignanciesOvarian cancer diagnosis and treatmentEndometriosis Research and Treatment0301 basic medicine03 medical and health sciences0302 clinical medicineHumansPeritoneal NeoplasmsInterleukin-6AnimalsMolecular Targeted TherapySignal TransductionInterleukin-6 Inhibitors

MeSH Terms

Interleukin-6 InhibitorsAnimalsHumansPeritoneal NeoplasmsSignal TransductionInterleukin-6Molecular Targeted Therapy

Keywords

MedicinePeritoneal carcinomatosisCancer researchPeritoneal cavityStromal cellOvarian cancerCytokineMesothelinImmunologyColorectal cancerCancerInternal medicineSurgeryIL-6Targeted TherapyTumor Immune MicroenvironmentInterleukin-6RReviewInterleukin-6 InhibitorsHumansAnimalsMolecular Targeted TherapyPeritoneal NeoplasmsSignal Transduction

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis

10.6084/m9.figshare.26994511figshare

Additional file 1 of Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis

10.6084/m9.figshare.26994511.v1figshare

Additional file 2 of Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis

10.6084/m9.figshare.26994514.v1figshare

Additional file 2 of Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis

10.6084/m9.figshare.26994514figshare

Additional file 3 of Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis

10.6084/m9.figshare.26994520.v1figshare

Additional file 3 of Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis

10.6084/m9.figshare.26994520figshare

Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis

FAIR Checklist

DataRank Breakdown

Top 5 citers driving the network score

Authors (12)

Funding (8 grants)

Impact

Open Access

Topics

Linked Datasets (6)

Annotations (Europe PMC)